Humana forward PE HUM
Share price divided by analysts' consensus earnings for the next twelve months, since 1996.
- Today, Oct 23, 2026
- 33.7×
- 10-year median
- 20.5×
- Against its 10-year history
- 98th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 11.8× to 37.1×
- Peer median
- 15.0×
Humana's forward PE is 33.7× as of Oct 23, 2026.
That is above its ten-year median of 20.5×, higher than on 98% of days in the last ten years.
Over that time it ranged from 11.8× in Oct 2019 to 37.1× in Jul 2026.
The median for 6 health insurers of a similar size is 15.0×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 33.7× | 15.5× | 37.1× |
| 2025 | 20.7× | 14.6× | 21.5× |
| 2024 | 15.3× | 14.0× | 29.9× |
| 2023 | 29.9× | 18.1× | 33.8× |
| 2022 | 19.2× | 16.6× | 21.5× |
| 2021 | 21.2× | 19.1× | 27.0× |
| 2020 | 25.3× | 15.0× | 31.0× |
| 2019 | 18.6× | 11.8× | 19.0× |
| 2018 | 17.0× | 16.6× | 23.1× |
| 2017 | 19.8× | 18.7× | 22.3× |
| 2016 | 20.2× | 16.5× | 21.2× |
| 2015 | 21.0× | 18.9× | 31.1× |
| 2014 | 19.2× | 12.8× | 19.3× |
| 2013 | 14.0× | 9.5× | 14.1× |
| 2012 | 9.7× | 9.0× | 13.3× |
| 2011 | 12.2× | 8.2× | 12.5× |
| 2010 | 7.9× | 7.2× | 9.2× |
| 2009 | 7.4× | 3.3× | 7.6× |
| 2008 | 6.3× | 4.4× | 20.0× |
| 2007 | 18.1× | 15.1× | 19.1× |
Against its peers
Companies in Medical - Healthcare Plans nearest Humana's size, closest first, today.
| Company | Forward PE |
|---|---|
| HUMHumana | 33.7× |
| CNCCentene | 15.0× |
| CICigna | 9.7× |
| ELVElevance Health | 16.1× |
| CVSCVS Health | 11.5× |
| OSCROscar Health | n/m |
| UNHUnitedHealth | 18.5× |
| Peer median | 15.0× |
Where Humana ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on Humana
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.